FDA Inspection 1063811 — Philosys Co. Ltd

Philosys Co. Ltd — FEI 3010172486

The FDA completed an inspection of Philosys Co. Ltd on Aug 30, 2018 in Gunsan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 30, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Gunsan (Korea (the Republic of))

Citations

IDCFRDescription
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.
64221 CFR 803.18(b)(1)(i)Adverse events--all info not in file

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.